Chimeric peptides targeting the receptor-binding domain of SARS-CoV-2 variants inhibit ACE2 interaction
The chimeric Trx-RB9 and Trx-RB10 peptides bind to the RBD of SARS-CoV-2 variants and inhibit the binding of ACE2 to the RBD of the Omicron trimeric S.
Authors
- Jiraporn Panmanee (ORCID: https://orcid.org/0000-0003-1541-7995)
- Surapon Piboonpocanun
- Ittipat Meewan (ORCID: https://orcid.org/0000-0002-4809-059X)
- Jukrapun Komaikul (ORCID: https://orcid.org/0000-0002-9957-3938)
- Promsin Masrinoul (ORCID: https://orcid.org/0009-0000-4091-5406)
- Pisit Ubonsri (ORCID: https://orcid.org/0000-0003-0614-4462)
Institutions
- Mahidol University (TH)
Publication Details
- Journal
- Asian Pacific Journal of Allergy and Immunology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.12932/ap-030424-1833
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mahidol University
- National Research Council of Thailand